Reneo Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Reneo Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2024.
  • Reneo Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $96K, a 32.4% decline year-over-year.
  • Reneo Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $500K, unchanged from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $96K -$46K -32.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $511K $142K +$11K +8.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $500K $169K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $100K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $100K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $131K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.